Summary

Brazilians are increasingly aware of the importance of preventative healthcare, which includes routine physicals and heart disease testing. This has boosted the demand for ECG equipment for screening and early diagnosis of heart conditions. Telemedicine is becoming more common in Brazil, particularly in remote and underserved areas. ECG equipment, a critical component of telemedicine, allows for remote monitoring of cardiac disorders and increases patient access to therapy. Heart disease is the leading cause of death in Brazil, and this trend is expected to continue as the population ages and lifestyles change. As a result, the demand for diagnostic and monitoring tools, such as ECG equipment, is increasing. Brazil has a high prevalence of cardiovascular disease, which can be attributed to factors such as urbanisation, sedentary lifestyles, and dietary changes. This prevalence fuels the demand for accurate and easily available cardiac diagnostic tools, raising ECG equipment's importance in the country's healthcare scene. Brazil's healthcare system is a hybrid of the public and private sectors, providing a wide range of services to the country's diverse population. ECG devices are widely used in both industries, although there are regional differences in accessibility and acceptance rates. Advanced healthcare facilities using cutting-edge ECG technologies may be found in major cities such as São Paulo and Rio de Janeiro. These metropolitan areas frequently set the standard for the adoption of novel ECG technologies and serve as hubs for specialised cardiac care.

According to the research report "Brazil Electrocardiograph (ECG) Market Overview, 2028," published by Bonafide Research, the Brazil Electrocardiograph (ECG) market is expected to reach market size of more than USD 300 Million by 2028. The Brazilian Health Regulatory Agency (ANVISA), which is in charge of regulating ECG equipment and other healthcare items in Brazil, also controls the country's regulatory framework and healthcare policies for the ECG equipment industry. The official title of the Brazilian government's authority in charge of regulating the documentation, development, arrival, and transmission of ECG equipment is ANVISA (National Health Surveillance Agency). Before ECG equipment can be distributed in Brazil, each component must be registered with ANVISA. The organisation also performs tests to ensure that the equipment meets safety and quality criteria. Brazil is recognised as a South American healthcare innovation engine, fostering medical technology research, development, and invention, including breakthroughs in ECG gadgets. Collaborations between academics, industry, and research institutions help to advance ECG technology in the country. Brazil's ECG market has substantial growth potential, owing to the country's huge population, rising healthcare expenditure, and rising cardiovascular disease prevalence. The market's growth reflects the increasing demand for improved ECG equipment in a variety of healthcare settings. Brazil is showing an increasing interest in sophisticated ECG technology, such as wireless and portable devices. Healthcare practitioners and facilities in the country are progressively embracing modern ECG systems with expanded functionality for more accurate diagnosis and patient-centred care.

Based on product market is segmented into resting electrocardiograph (ECG), stress electrocardiograph (ECG), holter monitors, event recorders and others. Among them resting electrocardiograph (ECG) product type is expected to play pivotal role in development of Brazil Electrocardiograph (ECG) market in upcoming time frame. In Brazil, there is a growing emphasis on preventive healthcare, with the goal of detecting and managing cardiac diseases at an early stage. ECG devices are critical in this approach because they provide a non-invasive and cost-effective way to screen people for cardiac problems, allowing for prompt interventions and preventive actions. Brazil is experiencing an increase in the prevalence of cardiovascular diseases as a result of lifestyle changes, urbanisation, and an ageing population. As cardiovascular disease remains a primary source of morbidity and mortality in the country, the demand for improved diagnostic tools such as ECGs grows. Brazil's government measures to improve healthcare access and infrastructure, as well as investments in healthcare technologies, create a favorable climate for the expansion of ECG devices. Policies that encourage technological innovation and healthcare modernization help to advance ECG technologies within the country. Based on end user segment market is bifurcated into hospitals & clinics, home settings & ambulatory surgical centers (ASCs) and others. Among them home settings segment is projected to grow at significant pace in Brazil Electrocardiograph (ECG) market during the forecast period owing to factors such as aging population, convenience of home healthcare and cost-effective healthcare factor are key factors driving the Brazil Electrocardiograph (ECG) market.

Considered in this report:
• Geography: Brazil
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Brazil Electrocardiograph (ECG) market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product:
• Resting Electrocardiograph (ECG)
• Stress Electrocardiograph (ECG)
• Holter Monitors
• Event Recorders
• Others

By End User:
• Hospitals & Clinics
• Home Settings & Ambulatory Surgical Centers (ASCs)
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Electrocardiograph (ECG) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents